Close Menu

NEW YORK (GenomeWeb) – MDxHealth today announced it has signed an agreement to include its recently acquired SelectMDx prostate cancer test in a prospective clinical trial at The Netherlands' Radboud University Medical Center.

The study is looking at the effectiveness of new technologies in prostate cancer testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.